Patent 7091029 was granted and assigned to Applied Genetics Technologies on August, 2006 by the United States Patent and Trademark Office.
The invention includes methods and compositions for the production of high titer recombinant adeno-associated virus (rAAV). The disclosed rAAV are useful in gene therapy applications. Methods are based on the use of recombinant herpes virus vectors and result in highly efficient production of rAAV.